Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics
Status:
Terminated
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Sodium pyruvate in sodium chloride solution will be delivered by nebulization to the lungs.
It is believed that this administration will produce bronchodilation in asthmatics as
determined by improvement in FEV1. FEV1 is a measure of lung function, and will be determined
after administration of sodium pyruvate. The study is a blinded, so subjects may receive
either the sodium pyruvate or a sodium chloride placebo. The primary endpoint will be the
improvement of FEV1 after 15 minutes in subjects receiving sodium pyruvate compared to the
FEV1 of subjects receiving the sodium chloride placebo.